Halozyme Therapeutics, Inc. (HALO) Social Stream
HALOZYME THERAPEUTICS INC (HALO) Price Targets From Analysts
Use the tables below to see what analysts covering HALOZYME THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 10 | $62 | $19 | $49.444 | $33.08 | 49.47% |
| 2021-11-24 | 10 | $62 | $19 | $49.125 | $33.08 | 48.5% |
| 2022-01-26 | 8 | $62 | $19 | $48.857 | $33.08 | 47.69% |
| 2022-02-23 | 8 | $62 | $19 | $48.714 | $33.08 | 47.26% |
| 2022-05-11 | 8 | $62 | $19 | $49.428 | $33.08 | 49.42% |
| 2022-05-13 | 8 | $62 | $19 | $49.142 | $33.08 | 48.56% |
| 2022-05-23 | 9 | $62 | $19 | $49.5 | $33.08 | 49.64% |
| 2022-05-26 | 8 | $60 | $19 | $49.25 | $33.08 | 48.88% |
| 2022-06-06 | 9 | $62 | $19 | $50.666 | $33.08 | 53.16% |
| 2022-08-10 | 7 | $60 | $21 | $50 | $33.08 | 51.15% |
| 2022-08-15 | 8 | $60 | $21 | $50 | $33.08 | 51.15% |
| 2022-10-26 | 9 | $60 | $21 | $50 | $33.08 | 51.15% |
| 2022-11-08 | 9 | $60 | $21 | $49.375 | $33.08 | 49.26% |
| 2022-11-14 | 9 | $62 | $23 | $52.444 | $33.08 | 58.54% |
| 2022-11-22 | 9 | $62 | $23 | $51.875 | $33.08 | 56.82% |
| 2022-11-28 | 9 | $65 | $23 | $53.333 | $33.08 | 61.22% |
| 2022-12-08 | 9 | $68 | $23 | $54.777 | $33.08 | 65.59% |
| 2022-12-21 | 9 | $68 | $23 | $56.111 | $33.08 | 69.62% |
| 2023-01-11 | 9 | $68 | $23 | $56 | $33.08 | 69.29% |
| 2023-02-22 | 9 | $68 | $26 | $56.333 | $33.08 | 70.29% |
| 2023-02-23 | 9 | $68 | $26 | $56.555 | $33.08 | 70.96% |
| 2023-03-03 | 9 | $68 | $26 | $56.444 | $33.08 | 70.63% |
| 2023-03-16 | 9 | $68 | $26 | $54.333 | $33.08 | 64.25% |
The Trend in the Analyst Price Target
Over the past 25 months, HALO's average price target has gone up $8.51.
HALO reports an average of 10.33% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-22 | 9 | 62 | 19 | 49.500 | 44.32 | 11.69% |
| 2022-05-26 | 10 | 60 | 19 | 49.250 | 46.60 | 5.69% |
| 2022-06-06 | 9 | 62 | 19 | 50.666 | 44.45 | 13.98% |
| 2022-11-28 | 9 | 65 | 23 | 53.333 | 56.47 | -5.56% |
| 2022-12-21 | 9 | 68 | 23 | 56.111 | 58.35 | -3.84% |
HALO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.78 | 6 | 0 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 33 months, HALO's average broker recommendation rating improved by 0.02.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HALO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HALOZYME THERAPEUTICS INC's variance in analysts' estimates is lower than -2576.94% of them.
- HALO has a greater upside potential (average analyst target price relative to current price) than 883.78% of Pharmaceutical Products stocks.
- HALO has a greater average analyst price target than 2295.64% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, HALOZYME THERAPEUTICS INC's number of analysts covering the stock is higher than 2221.56% of them.
Stocks similar to HALOZYME THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SGMO, VCEL, and BCRX.
View All Top Stocks by Price Target
Is HALO a Buy, Hold or Sell? See the POWR Ratings now!